PTGS2 and systemic lupus erythematosus: Apigenin suppresses IFN-γ and IL-17 responses in T cells from a lupus-prone mouse model and decreases cyclooxygenase-2 (COX-2) levels in lupus CD4+ T cells, B cells, dendritic cells, and macrophages, resulting in delayed disease progression [26].